Search - tctmd.com

Displaying 41 - 60 of 382

Sort: Relevancy | Date

Presentation TCT 2019

TCT 43: A Prospective Randomized Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus Eluting Stent in the Treatment of Subjects with up to two de novo Coronary Artery Lesions – BIOFLOW IV: 4 Years Clinical Results

Presenter: Bernhard Witzenbichler

September 25, 2019

Presentation TCT 2019

TCT 42: Polymer-free Drug-coated vs. Bare-metal Coronary Stents in Patients Undergoing Non-cardiac Surgery A Subgroup Analysis of the LEADERS FREE Trial

Presenter: Abdelhakim Allali

September 25, 2019

Presentation TCT 2019

TCT 41: A prospective multicentre randomized all-comers trial to assess the safety and effectiveness of the ultra-thin-strut sirolimus-eluting coronary stent Supraflex: 2-year results of the TALENT trial

Presenter: Azfar Zaman

September 25, 2019

News Conference News EuroPCR 2019

Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years

Michael O'Riordan

May 27, 2019

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Daily News

Three Years On, Absorb BVS Still Doesn’t Improve Myocardial Blood Flow

Michael O'Riordan

April 30, 2019

Presentation CIT 2019

A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Scaffold in Patients with Coronary Artery Disease (FUTURE-I) 3-Year Clinical and Imaging Outcomes

Presenter: Bo Xu

March 29, 2019

Presentation OPCI 2019

Impact of Intracoronary Imaging on the Evolution of PCI - From Balloon Angioplasty to Bioresorbable Scaffolds

Presenter: Gary S. Mintz

March 09, 2019

Even With PSP, Bioresorbable Scaffold Falls Short in ABSORB-COMPARE and ABSORB IV Trials

News Conference News TCT 2018

Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials

Michael O'Riordan

September 25, 2018

News Opinion Editor's Corner TCT 2018

TCT 2018, Day Four: Bioresorbable Scaffolds, Renal Denervation, Head-to-Head TAVR, INOCA, and . . . That’s a Wrap!

Shelley Wood

September 25, 2018

Presentation TCT Abstracts Posters 2018

Clinical Outcomes of Patients Undergoing Novolimus-eluting Bioresorbable Scaffolds

Presenter: Cigdem Koca Tari

September 25, 2018

Presentation TCT 2018

PEPCAD NSTEMI: A Randomized Trial Evaluating a Drug-Coated Balloon in Patients With Non-ST-Segment Elevation Myocardial Infarction

Presenter: Fernando Alfonso, Juan F. Granada, Bruno Scheller

September 23, 2018

Presentation TCT 2018

RESTORE SVD China: Randomized Trial of Drug-Coated Balloons vs Drug-Eluting Stents for Treatment of Small Vessel Disease

Presenter: Fernando Alfonso, Juan F. Granada, Runlin Gao

September 23, 2018

Presentation TCT 2018

RESTORE ISR China: A Randomized Trial of Two Different Drug-Coated Balloons for Treatment of In-Stent Restenosis After Drug-Eluting Stent Implantation

Presenter: Fernando Alfonso, Juan F. Granada, YunDai Chen

September 23, 2018

Presentation TCT 2018

BIOFLOW V: Two-Year Results of a Randomized Trial Evaluating an Ultra-Thin Strut Bioresorbable Polymer-Based Drug-Eluting Stent

Presenter: Fernando Alfonso, Juan F. Granada, David E. Kandzari

September 23, 2018

Presentation TCT 2018

I-LOVE-IT 2: Five-Year Results From a Randomized Trial of Biodegradable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents

Presenter: Michael Haude, Robert-Jan van Geuns, Yaling Han

September 23, 2018

Presentation TCT 2018

NEOVAS: Three-Year OCT and FFR Results From a Randomized Trial Evaluating a Polymeric Bioresorbable Scaffold

Presenter: Michael Haude, Robert-Jan van Geuns, Bo Xu

September 23, 2018

Presentation TCT 2018

BIOSOLVE-IV: Twelve-Month Outcomes With a Resorbable Magnesium Scaffold in a Real-world Setting

Presenter: Michael Haude, Robert-Jan van Geuns, Michael Kang-Yin Lee

September 23, 2018

Presentation TCT 2018

RENASCENT III: Nine-Month Clinical and Imaging Outcomes With a Thin-Strut (98 micrometer) Bioresorbable Coronary Scaffold

Presenter: Michael Haude, Robert-Jan van Geuns, Antonio Colombo

September 23, 2018

Presentation TCT 2018

Flash Debate: Metallic BRS Have the Edge!

Presenter: Ron Waksman

September 22, 2018

Advertisement

TCT 43: A Prospective Randomized Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus Eluting Stent in the Treatment of Subjects with up to two de novo Coronary Artery Lesions – BIOFLOW IV: 4 Years Clinical Results

TCT 42: Polymer-free Drug-coated vs. Bare-metal Coronary Stents in Patients Undergoing Non-cardiac Surgery A Subgroup Analysis of the LEADERS FREE Trial

TCT 41: A prospective multicentre randomized all-comers trial to assess the safety and effectiveness of the ultra-thin-strut sirolimus-eluting coronary stent Supraflex: 2-year results of the TALENT trial

Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Three Years On, Absorb BVS Still Doesn’t Improve Myocardial Blood Flow

A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Scaffold in Patients with Coronary Artery Disease (FUTURE-I) 3-Year Clinical and Imaging Outcomes

Impact of Intracoronary Imaging on the Evolution of PCI - From Balloon Angioplasty to Bioresorbable Scaffolds

Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials

TCT 2018, Day Four: Bioresorbable Scaffolds, Renal Denervation, Head-to-Head TAVR, INOCA, and . . . That’s a Wrap!

Clinical Outcomes of Patients Undergoing Novolimus-eluting Bioresorbable Scaffolds

PEPCAD NSTEMI: A Randomized Trial Evaluating a Drug-Coated Balloon in Patients With Non-ST-Segment Elevation Myocardial Infarction

RESTORE SVD China: Randomized Trial of Drug-Coated Balloons vs Drug-Eluting Stents for Treatment of Small Vessel Disease

RESTORE ISR China: A Randomized Trial of Two Different Drug-Coated Balloons for Treatment of In-Stent Restenosis After Drug-Eluting Stent Implantation

BIOFLOW V: Two-Year Results of a Randomized Trial Evaluating an Ultra-Thin Strut Bioresorbable Polymer-Based Drug-Eluting Stent

I-LOVE-IT 2: Five-Year Results From a Randomized Trial of Biodegradable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents

NEOVAS: Three-Year OCT and FFR Results From a Randomized Trial Evaluating a Polymeric Bioresorbable Scaffold

BIOSOLVE-IV: Twelve-Month Outcomes With a Resorbable Magnesium Scaffold in a Real-world Setting

RENASCENT III: Nine-Month Clinical and Imaging Outcomes With a Thin-Strut (98 micrometer) Bioresorbable Coronary Scaffold

Flash Debate: Metallic BRS Have the Edge!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content